The Actim Partus test to predict pre-term birth in asymptomatic high-risk women

The Actim Partus test has been shown to be a useful predictor of pre-term birth in symptomatic women, but limited research has been carried out in high-risk asymptomatic women. This is a pilot study to evaluate the use of this test as a direct comparator with the fetal fibronectin test. All asymptomatic high-risk women attending a pre-term surveillance clinic over a 9-month period, took an Actim Partus and fetal fibronectin test, between 23 +0–24 +6 weeks’ gestation. A total of 45 women were eligible. The positive and negative predictive values of the Actim Partus test for delivery at ≤ 37 weeks’ gestation were 0% and 70%, respectively, compared with the fetal fibronectin test, with values of 67% and 79%, respectively. It was concluded that the Actim Partus test did not perform well as a predictor of pre-term birth in high-risk asymptomatic women.

[1]  J. Paavonen,et al.  Elevated levels of decidual insulin‐like growth factor binding protein‐1 in cervical fluid in early and mid‐pregnancy are associated with an increased risk of spontaneous preterm delivery , 2010, BJOG : an international journal of obstetrics and gynaecology.

[2]  G. Yeo,et al.  Comparison of bedside test kits for prediction of preterm delivery: phosphorylated insulin-like growth factor binding protein-1 (pIGFBP-1) test and fetal fibronectin test. , 2007, Annals of the Academy of Medicine, Singapore.

[3]  E. Fonseca,et al.  Predicting preterm delivery in asymptomatic patients with prior preterm delivery by measurement of cervical length and phosphorylated insulin‐like growth factor‐binding protein‐1 , 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[4]  U. Nicolini,et al.  Cervical phIGFBP‐1 in the evaluation of the risk of preterm delivery , 2007, Acta obstetricia et gynecologica Scandinavica.

[5]  L. Poston,et al.  General obstetrics: A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study , 2006, BJOG : an international journal of obstetrics and gynaecology.

[6]  N. Uldbjerg.  Preterm delivery , 2005, Acta obstetricia et gynecologica Scandinavica.

[7]  E. Rutanen,et al.  Insulin-like growth factors in obstetrics , 2000, Current opinion in obstetrics & gynecology.

[8]  G. Lockitch,et al.  Fetal fibronectin improves the accuracy of diagnosis of preterm labor. , 1995, American journal of obstetrics and gynecology.